PharmiWeb.com - Global Pharma News & Resources
09-Dec-2021

Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share

Zur Rose Group AG / Key word(s): Capital Increase

09-Dec-2021 / 07:01 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Please find our press release about the completed capital increase under the following link:

https://zurrosegroup.com/websites/zurrosegroup/English/203015/capital-increase.html
 

End of ad hoc announcement
Language: English
Company: Zur Rose Group AG
Walzm├╝hlestrasse 60
8500 Frauenfeld
Switzerland
Phone: +41 52 724 08 14
Internet: www.zurrosegroup.com
ISIN: CH0042615283
Listed: SIX Swiss Exchange
EQS News ID: 1255736

 
End of Announcement EQS News Service

Editor Details

Last Updated: 09-Dec-2021